Travere Therapeutics (TVTX) Capital Expenditures Growth (3y) (2016 - 2025)
Travere Therapeutics (TVTX) Capital Expenditures Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Travere Therapeutics |
5.07 Bn |
4.99 Bn |
102.38 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
120.83% |
| Jun 30, 2024 |
-7.32% |
| Dec 31, 2023 |
26.50% |
| Sep 30, 2023 |
-83.93% |
| Jun 30, 2023 |
-78.69% |
| Mar 31, 2023 |
44.69% |
| Dec 31, 2022 |
32.57% |
| Sep 30, 2022 |
-63.39% |
| Jun 30, 2022 |
104.08% |
| Mar 31, 2022 |
90.33% |
| Dec 31, 2021 |
30.29% |
| Sep 30, 2021 |
40.44% |
| Jun 30, 2021 |
-43.20% |
| Mar 31, 2021 |
386.66% |
| Dec 31, 2020 |
-23.10% |
| Sep 30, 2020 |
84.89% |
| Jun 30, 2020 |
12.45% |
| Mar 31, 2020 |
-37.15% |
| Dec 31, 2019 |
-27.37% |
| Sep 30, 2019 |
92.76% |
